is metformin considered a glp 1 Diabetic Agents, From to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar Metformin and the Liver: Unlocking

However, the degree of appetite suppression may vary from person to person, and some individuals may start feeling the effects sooner than others

Ozempic is administered as a once-weekly subcutaneous injection , typically starting at a low dose (0.25 mg for 4 weeks) and gradually increasing to therapeutic doses of 0.5 mg, 1 mg, or 2 mg, depending on individual response and tolerability

They can be successfully managed medically, she said

"Way back, when there really weren't too many other agents for obesity treatment," she'd prescribe more of it, she told Insider, but that was largely because "there wasn't anything else." But metformin's effects on weight loss are "kind of mild," compared to newer drugs like semaglutide, Apovian said, and persistent side effects like stomach cramps and diarrhea are a common concern among patients taking metformin

Beyond weight loss: a case study and narrative review of the potential role of glucagon-like peptide-1 receptor agonists for the treatment of idiopathic intracranial hypertension